GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengdu Huasun Technology Group Inc Ltd (SZSE:000790) » Definitions » Debt-to-EBITDA

Chengdu Huasun Technology Group (SZSE:000790) Debt-to-EBITDA : 11.40 (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Chengdu Huasun Technology Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chengdu Huasun Technology Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥400.4 Mil. Chengdu Huasun Technology Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥16.5 Mil. Chengdu Huasun Technology Group's annualized EBITDA for the quarter that ended in Mar. 2024 was ¥36.6 Mil. Chengdu Huasun Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 11.40.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Chengdu Huasun Technology Group's Debt-to-EBITDA or its related term are showing as below:

SZSE:000790' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.5   Med: 1.23   Max: 25.47
Current: 9.77

During the past 13 years, the highest Debt-to-EBITDA Ratio of Chengdu Huasun Technology Group was 25.47. The lowest was 0.50. And the median was 1.23.

SZSE:000790's Debt-to-EBITDA is ranked worse than
90.02% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.7 vs SZSE:000790: 9.77

Chengdu Huasun Technology Group Debt-to-EBITDA Historical Data

The historical data trend for Chengdu Huasun Technology Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Huasun Technology Group Debt-to-EBITDA Chart

Chengdu Huasun Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.50 2.38 5.61

Chengdu Huasun Technology Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.42 4.76 8.41 55.00 11.40

Competitive Comparison of Chengdu Huasun Technology Group's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Chengdu Huasun Technology Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Huasun Technology Group's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengdu Huasun Technology Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Chengdu Huasun Technology Group's Debt-to-EBITDA falls into.



Chengdu Huasun Technology Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chengdu Huasun Technology Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(398.976 + 16.355) / 74.045
=5.61

Chengdu Huasun Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(400.383 + 16.536) / 36.584
=11.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Chengdu Huasun Technology Group  (SZSE:000790) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Chengdu Huasun Technology Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Chengdu Huasun Technology Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Huasun Technology Group (SZSE:000790) Business Description

Traded in Other Exchanges
N/A
Address
1168 Fuxin Avenue, High-tech Zone (West District), No. 101, 1st Floor, Building 2, Sichuan, Chengdu, CHN, 611731
Chengdu Huasun Technology Group Inc Ltd, formerly Chengdu Taihe Health Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. It is also involved in veterinary drugs, biological vaccines, and modern steel products.
Executives
Huang Xue Director
Wang Ren Guo Directors, executives
Ye Jing Executives
Jiang Li Executives
Bo Jian Ping Executives
Wang Tian Xiang Executives
Tang Ji Ying Executives
Li Jian Hua Executives
Wan Fang Executives
Wei Yi Guo Executives
Chen Zhong Qiao Director

Chengdu Huasun Technology Group (SZSE:000790) Headlines

No Headlines